Stephens Consulting, LLC Procept Bio Robotics Corp Transaction History
Stephens Consulting, LLC
- $399 Billion
- Q1 2025
A detailed history of Stephens Consulting, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Stephens Consulting, LLC holds 15 shares of PRCT stock, worth $801. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15Holding current value
$801% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
291Shares Held
40.1MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$275 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$186 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$93.6 Million0.05% of portfolio
-
Loomis Sayles & CO L P1.21MShares$64.5 Million0.12% of portfolio
-
State Street Corp Boston, MA1.19MShares$63.5 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.38B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...